A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

Anker Markus S, Haverkamp Wilhelm, Anker Stefan D

Charité-Universitätsmedizin Berlin, Berlin, Germany

N Engl J Med. 2018 Nov 8;379(19):1879. doi: 10.1056/NEJMc1811050.

Abstract

摘要

相似文献

N Engl J Med. 2018 Nov 8;379(19):1879. doi: 10.1056/NEJMc1811050.

N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971.

N Engl J Med. 2018 Nov 8;379(19):1879. doi: 10.1056/NEJMc1811050.

N Engl J Med. 2018 Nov 8;379(19):1880. doi: 10.1056/NEJMc1811050.

Exp Biol Med (Maywood). 2020 Jan;245(2):146-154. doi: 10.1177/1535370219900637. Epub 2020 Jan 27.

N Engl J Med. 2018 Jul 19;379(3):292-294. doi: 10.1056/NEJMe1800976.

Med Lett Drugs Ther. 2018 Jan 29;60(1539):21-22.

Pediatr Res. 1996 Jul;40(1):34-40. doi: 10.1203/00006450-199607000-00007.

J Pediatr Hematol Oncol. 2004 Oct;26(10):619-25.

Am J Nurs. 2017 Nov;117(11):20-21. doi: 10.1097/01.NAJ.0000526743.46055.ef.

Front Physiol. 2021 Mar 25;12:636609. doi: 10.3389/fphys.2021.636609. eCollection 2021.

Pain Med. 2020 Oct 1;21(10):2583-2592. doi: 10.1093/pm/pnaa002.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。